Induction therapy with thymoglobulin or interleukin-2 receptor antagonist for Chinese recipients of living donor renal transplantation: a retrospective study

BACKGROUND: Recipients of living donor renal transplantation are typically considered to have a relatively lower immunological risk. This retrospective study aimed to compare the therapeutic efficacy and safety between rabbit antithymocyte globulin (rATG) or interleukin-2 receptor antagonist (IL2-RA...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Jiang, Li, Jun, Chen, Guodong, Huang, Gang, Fu, Qian, Wang, Changxi, Chen, Lizhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429807/
https://www.ncbi.nlm.nih.gov/pubmed/30902050
http://dx.doi.org/10.1186/s12882-019-1293-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429807/
https://www.ncbi.nlm.nih.gov/pubmed/30902050
http://dx.doi.org/10.1186/s12882-019-1293-2

Ejemplares similares